Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
QuintilesIMS
McKesson
Mallinckrodt
Cerilliant
UBS
Moodys
Federal Trade Commission
US Army

Generated: June 20, 2018

DrugPatentWatch Database Preview

CINTICHEM TECHNETIUM 99M HEDSPA Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Cintichem Technetium 99m Hedspa, and when can generic versions of Cintichem Technetium 99m Hedspa launch?

Cintichem Technetium 99m Hedspa is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in CINTICHEM TECHNETIUM 99M HEDSPA is technetium tc-99m etidronate kit. There are four drug master file entries for this compound. Additional details are available on the technetium tc-99m etidronate kit profile page.
Summary for CINTICHEM TECHNETIUM 99M HEDSPA
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 85
Clinical Trials: 83
DailyMed Link:CINTICHEM TECHNETIUM 99M HEDSPA at DailyMed
Drug patent expirations by year for CINTICHEM TECHNETIUM 99M HEDSPA

US Patents and Regulatory Information for CINTICHEM TECHNETIUM 99M HEDSPA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare CINTICHEM TECHNETIUM 99M HEDSPA technetium tc-99m etidronate kit INJECTABLE;INJECTION 017653-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Fish and Richardson
Cerilliant
Dow
Mallinckrodt
Cipla
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.